These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 16217842)

  • 1. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.
    Dilba G; Bretz F; Hothorn LA; Guiard V
    Stat Med; 2006 Apr; 25(7):1131-47. PubMed ID: 16217842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-inferiority trials: the 'at least as good as' criterion with dichotomous data.
    Laster LL; Johnson MF; Kotler ML
    Stat Med; 2006 Apr; 25(7):1115-30. PubMed ID: 16381070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On non-inferiority margin and statistical tests in active control trials.
    Chow SC; Shao J
    Stat Med; 2006 Apr; 25(7):1101-13. PubMed ID: 16345042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimization of sample size when comparing two small probabilities in a non-inferiority safety trial.
    de Boo TM; Zielhuis GA
    Stat Med; 2004 Jun; 23(11):1683-99. PubMed ID: 15160402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mixed approach for proving non-inferiority in clinical trials with binary endpoints.
    Rousson V; Seifert B
    Biom J; 2008 Apr; 50(2):190-204. PubMed ID: 18311852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials.
    Lai TL; Shih MC; Zhu G
    Stat Med; 2006 Apr; 25(7):1149-67. PubMed ID: 16189814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic equivalence: fallacies and falsification.
    Garrett AD
    Stat Med; 2003 Mar; 22(5):741-62. PubMed ID: 12587103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
    Carroll KJ
    Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tests of equivalence and non-inferiority for diagnostic accuracy based on the paired areas under ROC curves.
    Liu JP; Ma MC; Wu CY; Tai JY
    Stat Med; 2006 Apr; 25(7):1219-38. PubMed ID: 16158400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choice of lambda-margin and dependency of non-inferiority trials.
    Tsong Y; Levenson M; Zhang J; Zhong J
    Stat Med; 2008 Feb; 27(4):520-8. PubMed ID: 17617797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A ratio test in active control non-inferiority trials with a time-to-event endpoint.
    Wang YC; Chen G; Chi GY
    J Biopharm Stat; 2006; 16(2):151-64. PubMed ID: 16584064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blinded sample size reassessment in non-inferiority and equivalence trials.
    Friede T; Kieser M
    Stat Med; 2003 Mar; 22(6):995-1007. PubMed ID: 12627414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing non-inferiority: a combination approach.
    Gao P; Ware JH
    Stat Med; 2008 Feb; 27(3):392-406. PubMed ID: 17575568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A framework for two-stage adaptive procedures to simultaneously test non-inferiority and superiority.
    Koyama T; Sampson AR; Gleser LJ
    Stat Med; 2005 Aug; 24(16):2439-56. PubMed ID: 15977285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size estimation for GEE method for comparing slopes in repeated measurements data.
    Jung SH; Ahn C
    Stat Med; 2003 Apr; 22(8):1305-15. PubMed ID: 12687656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials.
    Soonawala D; Middelburg RA; Egger M; Vandenbroucke JP; Dekkers OM
    Int J Epidemiol; 2010 Dec; 39(6):1567-81. PubMed ID: 20837637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
    Wang SJ; Hung HM; Tsong Y; Cui L
    Stat Med; 2001 Jul; 20(13):1903-12. PubMed ID: 11427948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple-arm superiority and non-inferiority designs with various endpoints.
    Chang M
    Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.